We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Israeli generic drugmaker Taro Pharmaceutical Industries has said it received clearance from the FDA for its new drug application for metronidazole topical gel USP, 0.75 percent.
Swiss drugmaker Novartis announced plans to build the first cell culture-derived influenza vaccines manufacturing plant in the United States at a site in Holly Springs, N.C., with construction expected to begin in 2007.
Sankyo's European unit, Daiichi Sankyo Europe, and Eli Lilly have signed an agreement to market and distribute Evista, an osteoporosis drug, in certain European countries.
India-based Biocon has entered into a licensing agreement with Bayer for the exclusive marketing and trademark rights for Insugen in the Chinese market.
Commonwealth Biotechnologies, Inc. and PharmAust, Ltd, an Australia-based biotech services company have signed a Strategic Alliance and Client Referral Agreement to co-market their services to the life sciences industry.
Panacea Biotec has informed the Bombay Stock Exchange that the Chairman Soshil Kumar Jain inaugurated a new pharmaceutical formulation facility of soft gelatin capsules' at the Baddi complex of the company in Himachal Pradesh.
DMV International, the pharmaceutical arm of Campina, a Netherlands-based dairy major and the business unit, Lactose New Zealand, a wholly owned subsidiary of Fonterra has teamed-up for excipients manufacture and research.
China Aoxing Pharmaceutical Corp. announced that its subsidiary, Hebei Aoxing Pharmaceutical Group, received new product approvals from the State Food and Drug Administration, P.R. China.
Following UK, Canada has also issued an advisory against the use of four Indian ayurvedic medicinal products that were found by Singapore's Health Science Authority to contain high levels of lead and/or mercury.